historical data Archives

AppWizard

February 23, 2026

MLB App Download For Android: Free & Easy

The official MLB app is available for free on Android devices, providing real-time game updates, in-depth statistics, breaking news, and the option to stream games (some features may require a subscription). It allows fans to follow their favorite teams and players, access detailed player stats, team performance metrics, standings, and historical data. The app can be downloaded from the Google Play Store by searching for "MLB" and tapping the "Install" button. Upon launching, users will find a clean design with sections for scores, schedules, news, and teams. Core features are free, but live game streaming requires an MLB.TV subscription. Common issues include the app not loading scores, crashing, or notification problems, which can often be resolved by checking the internet connection, clearing the app's cache, or adjusting notification settings.

Winsage

February 21, 2026

NetSpeedMonitor For Windows 10 64-Bit: A Simple Guide

NetSpeedMonitor is a free tool for Windows 10 64-bit that displays real-time upload and download speeds in the taskbar. It features real-time monitoring, taskbar integration, a customizable interface, low resource usage, and some historical data insights. It helps troubleshoot network issues, monitor data usage, and identify bandwidth-hogging applications. To download, users should search for compatible versions online, check user reviews, and download from trusted sources. Installation involves extracting files, running the installer, and selecting the appropriate network adapter. Configuration options include customizing display units, update intervals, and font colors. Alternatives to NetSpeedMonitor include DU Meter, NetWorx, GlassWire, and Windows Resource Monitor.

Tech Optimizer

February 15, 2026

Waystar Adopts EDB Postgres AI As Shares Trade Below Valuation Estimates

Waystar Holding is integrating EDB Postgres AI into its healthcare data operations to enhance secure and scalable transaction processing, aiming to consolidate payment and claims workloads in a regulated environment. The company processes healthcare payments for about half of the U.S. patient population, making data reliability and control crucial. The transition to EDB Postgres AI addresses the need to manage sensitive health information amid increasing electronic claims and digital payments. Waystar's stock price is currently at US, approximately 43% below the analyst target of US, and 35.8% below its estimated fair value, with an 18.9% decline over the past 30 days. The rollout of EDB Postgres AI is expected to impact uptime, client acquisitions, and operational efficiency, but there are execution risks associated with migrating critical workloads to a new database platform.

Tech Optimizer

January 31, 2026

Waystar Holding Taps EDB Postgres AI To Power Next‑Phase Growth

Waystar Holding (NasdaqGS:WAY) is integrating EDB Postgres AI into its healthcare payments platform to improve reliability and operational performance. This platform processes transactions for about half of the U.S. patient population. The adoption of EDB Postgres AI is expected to enhance efficiency in serving hospitals, clinics, and insurers. Waystar has previously embraced AI through its AltitudeAI offerings and the acquisition of Iodine Software, aligning with a broader initiative toward AI-driven automation. The partnership with EDB may improve processing reliability and streamline new automation features, but there are risks related to execution and competition from other companies enhancing their AI capabilities. Future metrics to monitor include uptime, processing speed, and the adoption of AI-driven workflows.

AppWizard

December 18, 2025

Steam’s 2025 Replay reveals we all once again spent around 14% of our time on games released in the same year—which apparently shakes out to a median of 0.56 new games

Players dedicated 14% of their total playtime in 2025 to games released in the same year. Historical data shows the following percentages for the same metric: 17% in 2022, 9% in 2023, and 15% in 2024. This suggests that, on average, players may settle around 14-15% of their gaming time on new releases in future years. For an average player logging 300 hours of gameplay, this equates to approximately 42 hours spent on titles that debuted in 2025. The median number of games played by users was four, implying engagement with about 0.56 new games.

Winsage

December 15, 2025

Still running Windows 10? Here’s why that’s a bad idea

Hundreds of millions of computers are still using Windows 10, despite it reaching its end-of-support deadline. An Extended Security Updates (ESU) subscription is available for free until October 2026, providing updates to help protect against security threats. By early 2021, around 100 million PCs were still running Windows 7, which had ceased receiving updates in January 2020, making them vulnerable to cyberattacks from groups like Digital Shadows, LockBit, Conti, and Vice Society. Notable incidents include the PrintNightmare flaw in July 2021, which led Microsoft to issue a patch for Windows 7, and the WannaCry attack in 2017, which targeted Windows XP machines. Microsoft releases monthly security fixes, and vulnerabilities like CVE-2025-62215, identified in November 2025, have been categorized as "Exploitation Detected." While current vulnerabilities require local access, history suggests that remote attacks may soon occur, posing severe risks to unpatched systems.

AppWizard

December 10, 2025

A Red Dead Redemption 2 fan conducted an in-game census to test Rockstar’s historical accuracy and found it wasn’t half bad: ‘It’s videogame-ified in a lot of ways, but not as much you might guess’

Red Dead Redemption 2 is set between 1899 and 1907 and features a detailed environment reflecting that era. YouTuber Any Austin conducted an in-game census of the fictional town of Valentine, analyzing metrics such as employment status, industry, income level, age, and overall health. He compared this data with real U.S. census statistics from 1907 and found that the game's representation of Valentine achieved a commendable level of accuracy.

AppWizard

November 22, 2025

Why Tandem Diabetes Care (TNDM) Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next

Tandem Diabetes Care has received FDA clearance for the Android version of the Tandem Mobi mobile app, set for limited release in December 2025 and broader availability in early 2026. This app will enhance accessibility to Tandem’s automated insulin delivery system for users with compatible Android smartphones. The company plans to launch the t:slim X2’s integration with Abbott’s FreeStyle Libre 3 Plus CGM sensor in October 2025, aiming to attract more continuous glucose monitoring users. Analysts project Tandem Diabetes Care could achieve .2 billion in revenue and .4 million in earnings by 2028, assuming a 7.5% annual revenue growth rate. Fair value estimates for the stock range from .64 to .57 per share, indicating a potential downside from its current market price.

AppWizard

November 15, 2025

Tandem Diabetes Care (TNDM) Is Up 31.5% After FDA Clears Android App for Insulin Management

Tandem Diabetes Care received FDA clearance for the Android version of its Tandem Mobi mobile app, allowing Android users to manage insulin delivery through its automated insulin pump system. The integration of Tandem's t:slim X2 with the Abbott FreeStyle Libre 3 Plus sensor was highlighted as a significant advancement in enhancing device connectivity. The company projects .2 billion in revenue and .4 million in earnings by 2028, requiring an annual revenue growth rate of 7.5% and an earnings increase from -5.5 million. Community fair value estimates for Tandem Diabetes Care range from .64 to .72.

AppWizard

November 13, 2025

Tandem Diabetes Care (TNDM) Is Up 23.1% After FDA Clears Android App for Mobi System – Has the Bull Case Changed?

In November 2025, Tandem Diabetes Care received FDA clearance for the Android version of its Tandem Mobi mobile app, allowing Android smartphone users in the U.S. to access its automated insulin delivery system. This development is expected to enhance patient engagement and support the company's growth in the insulin pump market. Tandem Diabetes Care is projected to reach .2 billion in revenue and generate 0.4 million in earnings by 2028, assuming a 7.5% annual growth rate. The fair value estimate for the company's stock ranges from .64 to [openai_gpt model="gpt-4o-mini" prompt="Summarize the content and extract only the fact described in the text bellow. The summary shall NOT include a title, introduction and conclusion. Text: In November 2025, Tandem Diabetes Care achieved a significant milestone with the FDA's clearance for the Android version of its Tandem Mobi mobile app. This development opens the door for a broader range of users, particularly Android smartphone owners in the United States, to access its automated insulin delivery system. Expanding Horizons The introduction of the Tandem Mobi app on Android devices not only enhances patient engagement but also paves the way for increased adoption of Tandem's innovative insulin delivery technology. This strategic move is expected to support the company's growth narrative in a competitive and rapidly evolving market landscape. Investors looking to stake their claim in Tandem Diabetes Care must have confidence in the company's capacity to drive the adoption of its insulin delivery solutions. The recent FDA approval for the Android app is a positive catalyst for attracting new patients. However, it does not entirely mitigate the ongoing risks associated with flat renewal rates and intensified competition within the U.S. insulin pump sector. By integrating the Tandem Mobi app with Android, Tandem Diabetes Care is poised to reach a wider audience, thereby enhancing flexibility in patient engagement. This milestone aims to address existing growth challenges, even as the company navigates rising execution risks linked to the transformation of its commercial organization and the complexities of entering new channels and international markets. Despite the promising expansion of product access, investors should remain cautious, as immediate benefits may not fully counterbalance the inherent risks associated with such rapid growth. Looking ahead, Tandem Diabetes Care is projected to reach .2 billion in revenue and generate .4 million in earnings by 2028, assuming an annual revenue growth rate of 7.5% and a substantial earnings increase from current losses. This optimistic outlook suggests a fair value estimate of .64 per share, indicating a potential 14% upside from its current market price. Community sentiment on Tandem's fair value varies significantly, with estimates ranging from .64 to .38 per share. While differing opinions reflect diverse expectations for the company's future, the execution risks tied to its commercial transformation remain a critical factor that could influence outcomes. Investors are encouraged to consider multiple perspectives when evaluating Tandem's potential. For those interested in delving deeper into Tandem Diabetes Care's financial landscape, a comprehensive analysis highlighting key rewards and risks is readily available. This resource simplifies the evaluation of the company's overall financial health, providing a clear visual summary for prospective investors. As the market continues to evolve, staying informed about developments in Tandem Diabetes Care and other related stocks is essential. The landscape is dynamic, and timely insights can be the key to making informed investment decisions. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology, and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives or financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned." max_tokens="3500" temperature="0.3" top_p="1.0" best_of="1" presence_penalty="0.1" frequency_penalty="frequency_penalty"].38 per share, with a potential 14% upside from its current market price.